Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 5/20 | 0.44 |
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.42 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4665190 | 1.00 | ALDH1A1 (0.58) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL9799553 | 0.85 | SMN1; SMN2 (0.53) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL10671620 | 0.85 | SMN1; SMN2 (0.53) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL10233426 | 0.85 | ALDH1A1 (0.47) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL10138310 | 0.85 | ALDH1A1 (0.47) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL3420945 | 0.82 | ALDH1A1 (0.41) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL3420951 | 0.82 | ALDH1A1 (0.41) | ALDH1A1HSD17B10GAAALOX15SMN1; SMN2 | |
| SCHEMBL9799529 | 0.81 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAALOX15MAPT | |
| SCHEMBL9799525 | 0.81 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAALOX15MAPT | |
| SCHEMBL13410418 | 0.80 | NR1I2 (0.47) | ALDH1A1GAASMN1; SMN2KDM4ECES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11884839-B2 | Acetal-protected silanol group-containing polysiloxane composition | NISSAN CHEMICAL CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| US-20230125270-A1 | RADIATION SENSITIVE COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-11561472-B2 | Radiation sensitive composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2023-01-24 | — | — | US | disclosed |
| EP-1472576-B1 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| US-20080286693-A1 | Sulfonate derivatives and the use thereof as latent acids | MATSUMOTO AKIRA | 2008-11-20 | — | — | US | disclosed |
| US-7326511-B2 | Sulfonate derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-05 | — | — | US | disclosed |
| US-20050153244-A1 | Sulfonate derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORP. | 2005-07-14 | — | — | US | disclosed |
| EP-1472576-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | Ciba SC Holding AG (CH) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003067332-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-14 | — | — | WO | disclosed |
| US-6512020-B1 | Photosensitive acid-donors in chemically amplified resist formulations. activated by irradiation with actinic electromagnetic radiation and electron beams. | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-01-28 | — | — | US | disclosed |
| US-6261738-B1 | LATENT CURING CATALYSTS FOR PHOTORESISTS SUCH AS 2,2,2-TRIFLUORO-1-PHENYL-ETHANONE OXIME-O-METHYL SULFONATE | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-17 | — | — | US | disclosed |
| US-5041663-A | Plant safening agents | CIBA-GEIGY CORPORATION (US) | 1991-08-20 | — | — | US | disclosed |
| US-5032169-A | Antidotes for herbicides | CIBA-GEIGY CORPORATION (US) | 1991-07-16 | — | — | US | disclosed |
| US-4759789-A | Treating locus of plant before or during application of herbicide with oxime ether compound | CIBA-GEIGY CORPORATION (US) | 1988-07-26 | — | — | US | disclosed |
| US-4707182-A | Phenoxine-ketal ethers, compositions containing them and the use thereof | CIBA-GEIGY CORPORATION (US) | 1987-11-17 | — | — | US | disclosed |
| US-4648895-A | ANTIDOTES | CIBA-GEIGY CORPORATION (US) | 1987-03-10 | — | — | US | disclosed |
| US-4576628-A | PLANT SAFENING AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-03-18 | — | — | US | disclosed |
| US-4566901-A | PLANT SAFENING AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-01-28 | — | — | US | disclosed |
| US-4530716-A | Plant safening agent | CIBA-GEIGY CORPORATION (US) | 1985-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11561472-B2 | Radiation sensitive composition | RER1, RAD1, RAD51 | ALDH1A1 2201/4885HSD17B10 1633/4885GAA 1412/4885 |
| US-20230125270-A1 | RADIATION SENSITIVE COMPOSITION | XRCC6, RAD50, XRCC5 | ALDH1A1 1388/4885HSD17B10 698/4885GAA 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.